216 results
AACE/ACE ASCVD Risk Factor Modifications Algorithm

#ASCVD #RiskFactor #Modifications #Algorithm #Management #AACE
AACE/ACE ASCVD Risk ... Modifications Algorithm #ASCVD ... Algorithm #Management #AACE
The recommended approach to the initiation of statin therapy in hyperlipidemia. 

Low-intensity:
-Lovastatin 20 mg
-Pravastatin 10-20 mg

Intermediate
hyperlipidemia #statintherapy ... atheroscleroticcardiovasculardisease #ascvd
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
events in T2DM + ASCVD ... or ASCVD risk; ... had no effect on MACE ... , in T2DM + ASCVD ... or ASCVD risk.
The Evidence for Aspirin - Visual Abstract

Three new aspirin trials in three different populations: 
 -
Moderate Risk (ASCVD ... > 20%) <-> MACE ... Diabetes <-> MACE ... Age > 70 <-> MACE
AACE/ACE 2018 Glycemic Control Algorithm

#AACE #2018 #Glycemic #Diabetes #DM2 #Control #Medication #Algorithm #Endocrinology #PrimaryCare #Management
AACE/ACE 2018 Glycemic ... Control Algorithm #AACE
Diabetes Type 2 Medication Management and Titration Algorithm
- First line therapy is metformin and comprehensive lifestyle
- Established ASCVD ... Without established ASCVD
Mesenteric Ischemia - Differential Diagnostic Schema
Chronic: ASCVD, Venous, Vasculitides 5% (PAN, [E]GPA, IgA, MPA)
Acute
 - Venous
Schema Chronic: ASCVD ... hypo-/akinesis), ASCVD ... failure, Dissection, ASCVD
ABCDE of Primary ASCVD Prevention: Lifestyle Changes and Team-Based Care - Checklist
A – Antiplatelet Therapy
B –
ABCDE of Primary ASCVD ... #PrimaryCare #ASCVD
Lifestyle Therapy for Diabetes - AACE 2018 Guidelines

#Lifestyle #Modifications #Therapy #Diabetes #DM2 #AACE #2018 #Guidelines #Management
for Diabetes - AACE ... Diabetes #DM2 #AACE
ABCDE of Primary Prevention: Lifestyle Changes and Team-Based Care - Checklist
A – Antiplatelet Therapy
B – Blood
#PrimaryCare #ASCVD